Asthma Spacers Market to Reach US$ 1,803.93 Mn by 2026

Asthma Spacers Market Segmentation by Product Type
- Aerochamber, Optichamber, Volumatic, Inspirease;
Distribution Channel - Retail Pharmacy, Hospital
Pharmacy, E-commerce, and Forecast 2018 - 2026
©2019 Transparency Market Research, All Rights Reserved

Sr. No.
Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Chapter 8
Chapter 9
Chapter 10
Chapter 11
Chapter 12
Chapter 13
Chapter 14
Content
Preface
Assumptions and Research Methodology
Market Overview
Market Dynamics
Global Asthma Spacers Market Analysis and Forecasts, By Software Type
Global Asthma Spacers Market Analysis, by Modality
Global Asthma Spacers Market Analysis, by Application
Global Asthma Spacers Market Analysis, by End-user
Global Asthma Spacers Market Analysis and Forecast by Region
Europe Asthma Spacers Market Analysis and Forecast
Asia Pacific Asthma Spacers Market Analysis and Forecast
Latin America Asthma Spacers Market Analysis and Forecast
Middle East & Africa Asthma Spacers Market Analysis and Forecast
Competition Landscape
©2019 Transparency Market Research, All Rights Reserved

Asthma is a chronic respiratory condition that affects millions of people around the
world.
Aerosol drug delivery is the first line administration route in asthma management,
and metered dose inhalers (MDIs) are the most common type of inhalers used in
asthmatic conditions.
A spacer, usually attached with an MDI, is an external device that provides better
drug delivery by increasing inhalation and actuation.
Spacers with metered dose inhalers are used to treat several respiratory diseases
such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
©2019 Transparency Market Research, All Rights Reserved

The global asthma spacers market is expected to expand at a CAGR of 3.7%
from 2018 to 2026.
Technological advancements in spacer devices is likely to propel the market in the
near future.
Use of spacers/valve holding chambers minimizes issues related to the inhalation
technique. It reduces oropharyngeal deposition and increases lung deposition,
which, in turn, boosts the adoption of asthma spacers for the proper management of
asthma.
According to the WHO, around 235 million people are affected by asthma, and by
the end of 2025, the number is likely to rise by 100 million globally.
©2019 Transparency Market Research, All Rights Reserved

Rise in the prevalence rate of asthma is creating a significant socioeconomic impact
across the globe, which, in turn, is propelling the demand for asthma spacers.
Inhalation is the first line administration route for asthma management. Nebulizers
and metered dose inhalers are widely used for the management of asthma.
Key players profiled in this report are Koninklijke Philips N.V, Trudell Medical
International, Medical Development International, Merck & Co., Pari Gmbh,
AstraZeneca, and GlaxoSmithKline plc.
Companies operating in the global asthma spacers market focus on strategic
collaborations to develop new products in the emerging regions such as Asia
Pacific and Latin America.
©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website
www.transparencymarketresearch.com
For sales queries or new topics email us on:
sales@transparencymarketresearch.com
Thank You
©2019 Transparency Market Research, All Rights Reserved